greeksoup/ stock research
Stock research / United States / NBIX / Planned sales

Neurocrine Biosciences Inc. planned insider sales

In the twelve months since 9 October 2025 insiders at Neurocrine Biosciences Inc. filed 25 Form 144 notices of planned sales, 510,897 shares worth $79.9 million at the time of filing, from 16 sellers. The latest, filed 14 September 2026: Matthew C Abernethy (officer), 2,311 shares worth $361,024, planned for around 14 September 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.

FiledSellerRelationshipSharesValuePlanned saleBrokerHow acquiredFiling
14 September 2026Matthew C AbernethyOfficer2,311$361,02414 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesPerformance Stock UnitsForm 144
14 September 2026David Warren BoyerOfficer4,714$736,42114 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted and Performance Stock UnitsForm 144
9 September 2026Eric BenevichOfficer2,154$334,1509 September 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
10 July 2026Ingrid DelaetOfficer4,367$788,46210 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
9 July 2026Darin LippoldtOfficer10,000$1.8 million9 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
7 July 2026Ingrid DelaetOfficer14,571$2.5 million7 July 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
29 June 2026Darin LippoldtOfficer9,800$1.7 million29 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
26 June 2026Darin LippoldtOfficer200$32,83626 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
5 June 2026Stephen SherwinDirector25,000$4.2 million5 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
2 June 2026Julie CookeOfficer36,937$5.9 million2 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock Options; Previously Exercised Stock Options; Restricted and Performance Stock UnitsForm 144
1 June 2026Jude OnyiaOfficer11,000$1.7 million1 June 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
29 May 2026Ingrid DelaetOfficer2,261$353,59829 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
27 May 2026Jude OnyiaOfficer11,000$1.7 million27 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
26 May 2026David Warren BoyerOfficer3,888$609,25026 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock Awards / Performance Stock UnitsForm 144
19 May 2026Kevin Charles GormanDirector245,088$38.5 million19 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock Options; Previously Vested RSUs & PSUsForm 144
15 May 2026Richard F PopsDirector15,000$2.4 million15 May 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
12 May 2026Norwalk Leslie VDirector6,310$1.0 million12 May 2026THE CHARLES SCHWAB CORPORATIONSTOCK OPTION EXERCISEForm 144
16 January 2026Kyle GanoOfficer36,400$4.9 million16 January 2026Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
15 December 2025Norwalk Leslie VDirector11,250$1.7 million15 December 2025THE CHARLES SCHWAB CORPORATIONSTOCK OPTION EXERCISEForm 144
8 December 2025Darin LippoldtOfficer4,376$680,5128 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
3 December 2025Gary A Lyons Revocable Living U/A Dtd 06/08/2012Director15,000$2.3 million3 December 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
28 November 2025Eric BenevichOfficer5,970$904,93328 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
25 November 2025George MorrowDirector15,000$2.1 million25 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
5 November 2025Gano KyleOfficer, Director300$42,5914 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesRestricted Stock UnitsForm 144
5 November 2025William H. RastetterDirector18,000$2.6 million5 November 2025Morgan Stanley Smith Barney LLC Executive Financial ServicesExercise of Stock OptionsForm 144
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.
Read moreValue is the filer's own aggregate market value. Whether the sale happened shows up later on Form 4, on the insiders page.

Source

Form 144 filings on EDGAR for Neurocrine Biosciences Inc.: the company's filing index, each notice read from its own XML.

The same record on your computer

GreekSoup is also a free program for your own computer. It reads these same filings for the names you follow, refreshed as they land, with no account. One pasted line installs it.

Install